Primary tabs

Ticagrelor Potentiation of Remote Ischemic Preconditioning: The Ticagrelor in Remote Ischemic Preconditioning TRIP study

The primary objective of this study is to demonstrate superior efficacy of a combination of ticagrelor and RIPC in the reduction of PMI compared to a clopidogrel-RIPC combination or ticagrelor alone by evaluating post-procedural cardiac Troponin I cTnI levels defined as cTnI at 24 hours post-PCI

Additional Information

FieldValue
mimetypeapplication/json
filesize10.8 KB
resource typefile upload
timestampMar 13, 2020